Efficacia delle cellule CAR-T sui neuroblastomi. Le cellule CAR T sono efficaci contro i neuroblastomi, tumori solidi che colpiscono i bambini. Per la prima volta una terapia genica con cellule CAR T si è dimostrata in grado di trattare con successo i neuroblastomi, tumori solidi che possono manifestarsi in età pediatrica.
#celluleCART #ChimericAntigenReceptor #neuroblastoma #tumorecervello
https://scienzamagia.eu/medicina-e-benessere/efficacia-delle-cellule-car-t-sui-neuroblastomi/
#cellulecart #chimericantigenreceptor #neuroblastoma #tumorecervello
“Multiple provinces are investing in a form of T-cell therapy that could offer hope for cancer patients who are running out of treatment options, according to an Ontario physician.
#ChimericAntigenReceptor (#CAR) T-cell therapy is a new treatment that targets certain types of blood cancers, specifically forms of #leukemia and #lymphoma”
#chimericantigenreceptor #car #Leukemia #lymphoma
RT @NCIsysbio
Dr. Nicholas Graham, @USCSysBio_Lab, et al. @USCViterbi #NCICSBC are investigating #ChimericAntigenReceptor (CAR)-mediated Natural Killer cell signaling to inform the design of #immunotherapies for #multiplemyeloma. https://reporter.nih.gov/search/xb8Mbt37xEO5MhSqAhNPhQ/project-details/10557760
#ncicsbc #chimericantigenreceptor #immunotherapies #multiplemyeloma